Cavities are compared using Shaper.
For more information, please see the following publication:
Desaphy J. et al. Comparison and Druggability Prediction of protein-Ligand Binding sites from pharmacophore-annotated cavity shapes J. Chem. Inf. Model., 2012, 52(8), pp2287-2299
| PDB ID | HET | Uniprot Name | EC Number |
|---|---|---|---|
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 |
| PDB ID | HET | Uniprot Name | EC Number | Cavity Similarity |
Align |
|---|---|---|---|---|---|
| 3cjg | KIM | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 1.000 | |
| 2p2h | 994 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.542 | |
| 4nks | 2M2 | Fibroblast growth factor receptor 1 | / | 0.541 | |
| 4nka | 2K7 | Fibroblast growth factor receptor 1 | / | 0.537 | |
| 3b8r | 887 | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.535 | |
| 3lcd | BDY | Macrophage colony-stimulating factor 1 receptor | 2.7.10.1 | 0.532 | |
| 4f64 | 0S8 | Fibroblast growth factor receptor 1 | / | 0.529 | |
| 4gmy | 0X5 | Tyrosine-protein kinase JAK2 | / | 0.511 | |
| 2py3 | ACP | Fibroblast growth factor receptor 2 | / | 0.509 | |
| 1qpj | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.506 | |
| 4j97 | ACP | Fibroblast growth factor receptor 2 | / | 0.506 | |
| 3vs7 | KS1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.500 | |
| 4xli | 1N1 | Abelson tyrosine-protein kinase 2 | 2.7.10.2 | 0.500 | |
| 3qlg | 1N1 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.497 | |
| 2ivu | ZD6 | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.496 | |
| 4bc6 | XZN | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.496 | |
| 4ic7 | ANP | Mitogen-activated protein kinase 7 | 2.7.11.24 | 0.496 | |
| 2pwl | ACP | Fibroblast growth factor receptor 2 | / | 0.494 | |
| 5d12 | G97 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.494 | |
| 3vjo | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.490 | |
| 4mxy | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.490 | |
| 4mxz | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.490 | |
| 5aaa | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.488 | |
| 4hvh | 19R | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.487 | |
| 4j95 | ACP | Fibroblast growth factor receptor 2 | / | 0.487 | |
| 2h8h | H8H | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.486 | |
| 3b2w | 9NH | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.486 | |
| 2hog | 710 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.484 | |
| 4anq | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.484 | |
| 3s4q | NK0 | Mitogen-activated protein kinase 14 | / | 0.482 | |
| 2bdf | 24A | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.481 | |
| 2c0i | L1G | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 3vrz | VRZ | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.481 | |
| 4fic | 0UL | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.480 | |
| 4fob | 0US | ALK tyrosine kinase receptor | 2.7.10.1 | 0.480 | |
| 3zew | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.479 | |
| 4jia | 1K3 | Tyrosine-protein kinase JAK2 | / | 0.479 | |
| 3qlf | PD5 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.478 | |
| 4gk2 | L66 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.478 | |
| 2of2 | 547 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.477 | |
| 4c62 | XWW | Tyrosine-protein kinase JAK2 | / | 0.477 | |
| 1qpd | STU | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.476 | |
| 4fr4 | STU | Serine/threonine-protein kinase 32A | 2.7.11.1 | 0.476 | |
| 2fgi | PD1 | Fibroblast growth factor receptor 1 | / | 0.475 | |
| 2of4 | 979 | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.475 | |
| 4aot | GW8 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.475 | |
| 4cd0 | AWJ | ALK tyrosine kinase receptor | 2.7.10.1 | 0.475 | |
| 4gk4 | L90 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.475 | |
| 2gcd | STU | Serine/threonine-protein kinase TAO2 | 2.7.11.1 | 0.474 | |
| 2q0b | ACP | Fibroblast growth factor receptor 2 | / | 0.474 | |
| 2xyu | Q9G | Ephrin type-A receptor 4 | 2.7.10.1 | 0.474 | |
| 2j7t | 274 | Serine/threonine-protein kinase 10 | 2.7.11.1 | 0.473 | |
| 2hk5 | 1BM | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.472 | |
| 4f63 | 0S7 | Fibroblast growth factor receptor 1 | / | 0.472 | |
| 4ftt | 6HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.471 | |
| 2dq7 | STU | Tyrosine-protein kinase Fyn | 2.7.10.2 | 0.470 | |
| 1fin | ATP | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.469 | |
| 1yol | S03 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.469 | |
| 4k33 | ACP | Fibroblast growth factor receptor 3 | 2.7.10.1 | 0.468 | |
| 2itq | ITQ | Epidermal growth factor receptor | 2.7.10.1 | 0.467 | |
| 4fsq | HK3 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.467 | |
| 2c6e | HPM | Aurora kinase A | 2.7.11.1 | 0.466 | |
| 2xp2 | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.466 | |
| 2yn8 | STU | Ephrin type-B receptor 4 | 2.7.10.1 | 0.466 | |
| 3c7q | XIN | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.466 | |
| 5aac | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.466 | |
| 2qo9 | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.465 | |
| 2xvd | AS6 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.465 | |
| 3uvq | FS8 | Mitogen-activated protein kinase 14 | / | 0.465 | |
| 3w2s | W2R | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 4dgg | I76 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.465 | |
| 4nk9 | 2K5 | Fibroblast growth factor receptor 1 | / | 0.465 | |
| 4wkq | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.465 | |
| 4bid | IE8 | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.464 | |
| 3c4x | ATP | Rhodopsin kinase | / | 0.463 | |
| 3ckx | STU | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.463 | |
| 4fti | H7K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 4ftk | H9K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.463 | |
| 4id7 | 1G0 | Activated CDC42 kinase 1 | / | 0.463 | |
| 2pzp | ACP | Fibroblast growth factor receptor 2 | / | 0.462 | |
| 3vs3 | VSE | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.462 | |
| 1q3w | ATU | Glycogen synthase kinase-3 beta | 2.7.11.26 | 0.461 | |
| 2r0u | M54 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
| 2vwu | 7X1 | Ephrin type-B receptor 4 | 2.7.10.1 | 0.461 | |
| 4ans | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.461 | |
| 4fsr | HKC | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.461 | |
| 3a62 | STU | Ribosomal protein S6 kinase beta-1 | 2.7.11.1 | 0.458 | |
| 3vs2 | VSB | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.458 | |
| 4mcv | 29K | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.458 | |
| 2ydi | YDI | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.457 | |
| 3cjf | SAV | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.457 | |
| 4k11 | 0J9 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.457 | |
| 2yfx | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.456 | |
| 4gk3 | L87 | Ephrin type-A receptor 3 | 2.7.10.1 | 0.456 | |
| 2hy0 | 306 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.455 | |
| 2qoq | ANP | Ephrin type-A receptor 3 | 2.7.10.1 | 0.455 | |
| 4mxo | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 4mxx | DB8 | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.455 | |
| 4qmn | DB8 | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.455 | |
| 2zyb | KSL | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.454 | |
| 3v8w | 0G2 | Tyrosine-protein kinase ITK/TSK | 2.7.10.2 | 0.454 | |
| 4btk | DTQ | Tau-tubulin kinase 1 | 2.7.11.1 | 0.454 | |
| 4ftm | 1HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.454 | |
| 4hyu | 1BK | Mitogen-activated protein kinase 8 | 2.7.11.24 | 0.454 | |
| 5dr9 | SKE | Aurora kinase A | 2.7.11.1 | 0.454 | |
| 1nvs | UCM | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.453 | |
| 1pkd | UCN | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.453 | |
| 2eb3 | ANP | Epidermal growth factor receptor | 2.7.10.1 | 0.453 | |
| 3vid | 4TT | Vascular endothelial growth factor receptor 2 | 2.7.10.1 | 0.453 | |
| 4tyj | 0LI | Fibroblast growth factor receptor 4 | 2.7.10.1 | 0.453 | |
| 4y95 | 746 | Tyrosine-protein kinase | / | 0.453 | |
| 2etm | 7PY | Focal adhesion kinase 1 | 2.7.10.2 | 0.452 | |
| 2hy8 | 1ST | Serine/threonine-protein kinase PAK 1 | 2.7.11.1 | 0.452 | |
| 3fls | FLS | Mitogen-activated protein kinase 14 | / | 0.452 | |
| 4g31 | 0WH | Eukaryotic translation initiation factor 2-alpha kinase 3 | 2.7.11.1 | 0.452 | |
| 4hvg | 19Q | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.452 | |
| 4i23 | 1C9 | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 4riy | ADP | Epidermal growth factor receptor | 2.7.10.1 | 0.451 | |
| 5aab | VGH | ALK tyrosine kinase receptor | 2.7.10.1 | 0.451 | |
| 5auw | QUE | Death-associated protein kinase 1 | 2.7.11.1 | 0.451 | |
| 2hxl | 422 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 2i0e | PDS | Protein kinase C beta type | 2.7.11.13 | 0.450 | |
| 2vd5 | BI8 | Myotonin-protein kinase | 2.7.11.1 | 0.450 | |
| 3gc9 | B45 | Mitogen-activated protein kinase 11 | 2.7.11.24 | 0.450 | |
| 3tki | S25 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.450 | |
| 4flh | 14K | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 2.7.1.153 | 0.450 | |
| 2pzr | ACP | Fibroblast growth factor receptor 2 | / | 0.449 | |
| 2y6o | 1N1 | Ephrin type-A receptor 4 | 2.7.10.1 | 0.449 | |
| 4y93 | 746 | Tyrosine-protein kinase | / | 0.449 | |
| 1qcf | PP1 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.448 | |
| 2r7b | 253 | 3-phosphoinositide-dependent protein kinase 1 | 2.7.11.1 | 0.448 | |
| 4eym | 0RX | Mitogen-activated protein kinase 13 | 2.7.11.24 | 0.448 | |
| 1u59 | STU | Tyrosine-protein kinase ZAP-70 | 2.7.10.2 | 0.447 | |
| 2zm1 | KSF | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.447 | |
| 3vs5 | VSG | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.447 | |
| 4bdg | P3J | Serine/threonine-protein kinase Chk2 | 2.7.11.1 | 0.447 | |
| 2ayp | 43A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 3qc9 | ADP | Rhodopsin kinase | / | 0.446 | |
| 4e4m | 0NH | Tyrosine-protein kinase JAK2 | / | 0.446 | |
| 4ft9 | H4K | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.446 | |
| 1zyj | BI5 | Mitogen-activated protein kinase 14 | / | 0.445 | |
| 2itz | IRE | Epidermal growth factor receptor | 2.7.10.1 | 0.445 | |
| 2bdj | HET | Proto-oncogene tyrosine-protein kinase Src | 2.7.10.2 | 0.444 | |
| 3ad6 | KSC | Tyrosine-protein kinase Lck | 2.7.10.2 | 0.444 | |
| 3vs0 | VS0 | Tyrosine-protein kinase HCK | 2.7.10.2 | 0.444 | |
| 4bf2 | STU | Mitogen-activated protein kinase kinase kinase 5 | 2.7.11.25 | 0.444 | |
| 2buj | STU | Serine/threonine-protein kinase 16 | / | 0.443 | |
| 2e9n | 76A | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.443 | |
| 3mfs | ANP | Peripheral plasma membrane protein CASK | 2.7.11.1 | 0.443 | |
| 4hvi | 19S | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.443 | |
| 5amn | DTQ | Proto-oncogene tyrosine-protein kinase receptor Ret | 2.7.10.1 | 0.443 | |
| 3eb0 | DRK | Uncharacterized protein | / | 0.442 | |
| 3oom | 507 | Activin receptor type-1 | 2.7.11.30 | 0.442 | |
| 3tkh | 07S | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 3w33 | W19 | Epidermal growth factor receptor | 2.7.10.1 | 0.442 | |
| 4fst | HK4 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.442 | |
| 1ir3 | ANP | Insulin receptor | 2.7.10.1 | 0.441 | |
| 2wmu | ZYU | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.441 | |
| 3cd3 | STU | Tyrosine-protein kinase Fes/Fps | 2.7.10.2 | 0.441 | |
| 3hx4 | ANP | Calmodulin-domain protein kinase 1 | / | 0.441 | |
| 4jrv | KJV | Epidermal growth factor receptor | 2.7.10.1 | 0.441 | |
| 4qml | ANP | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.441 | |
| 5bvw | 1N1 | Epithelial discoidin domain-containing receptor 1 | 2.7.10.1 | 0.441 | |
| 1yvj | 4ST | Tyrosine-protein kinase JAK3 | 2.7.10.2 | 0.440 | |
| 1zrz | BI1 | Protein kinase C iota type | 2.7.11.13 | 0.440 | |
| 2hxq | 373 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 2izs | BRQ | Casein kinase I isoform gamma-3 | 2.7.11.1 | 0.440 | |
| 2pz5 | ACP | Fibroblast growth factor receptor 2 | / | 0.440 | |
| 2ym6 | YM6 | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 3q92 | XNB | Ketohexokinase | / | 0.440 | |
| 3t8o | ATP | Rhodopsin kinase | / | 0.440 | |
| 3tnw | F18 | Cyclin-dependent kinase 2 | 2.7.11.22 | 0.440 | |
| 4fg7 | ATP | Calcium/calmodulin-dependent protein kinase type 1 | 2.7.11.17 | 0.440 | |
| 4ftn | 2HK | Serine/threonine-protein kinase Chk1 | 2.7.11.1 | 0.440 | |
| 4i0r | 1B4 | Tyrosine-protein kinase SYK | 2.7.10.2 | 0.440 | |
| 4ieb | ANP | Calmodulin-domain protein kinase 1 | / | 0.440 | |
| 4qmx | H8H | Serine/threonine-protein kinase 24 | 2.7.11.1 | 0.440 |